Infectious Diagnostics Market Size, Share and Growth, Analysis and Forecast – 2024
- OI-62 |
- Published date: Jan, 2019 |
- In Vitro Diagnostics |
- Pages
The report covers forecast and analysis for the infectious disease diagnostics market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2017 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the infectious disease diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the infectious disease diagnostics market on a global level.
The global infectious disease diagnostics market is expected to reach USD 20.45 Billion by 2024 from USD 14.73 Billion in 2017, at a CAGR of 5.7
In order to give the users of this report a comprehensive view on the infectious disease diagnostics market. The study encompasses a market attractiveness analysis, where product type, test type, applications, end-user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.
It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch
The report covers forecast and analysis for the infectious disease diagnostics market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the infectious disease diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the infectious disease diagnostics market on a global level.
The global infectious disease diagnostics market is expected to reach USD 20.45 Billion by 2024 from USD 14.73 Billion in 2017, at a CAGR of 5.7
In order to give the users of this report a comprehensive view on the infectious disease diagnostics market. The study encompasses a market attractiveness analysis, where product type, test type, applications, end-user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.
It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
